Helga E. de Vries

Active 1989–2025

153
Papers
18,355
Citations
85
h-index
148
i10-index

Citations

Citations per year for Helga E. de Vries1992: 1 citations1993: 2 citations1994: 1 citations1995: 1 citations1997: 12 citations1998: 8 citations1999: 22 citations2000: 29 citations2001: 22 citations2002: 24 citations2003: 42 citations2004: 49 citations2005: 54 citations2006: 73 citations2007: 94 citations2008: 128 citations2009: 110 citations2010: 132 citations2011: 179 citations2012: 202 citations2013: 233 citations2014: 242 citations2015: 304 citations2016: 219 citations2017: 226 citations2018: 236 citations2019: 653 citations2020: 851 citations2021: 917 citations2022: 794 citations2023: 573 citations2024: 918 citations2025: 537 citations2026: 9 citations1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,242 citing papers, 22.6% of this breakdownChina: 1,171 citing papers, 11.8% of this breakdownUnited Kingdom: 617 citing papers, 6.2% of this breakdownGermany: 613 citing papers, 6.2% of this breakdownNetherlands: 510 citing papers, 5.1% of this breakdownItaly: 465 citing papers, 4.7% of this breakdownCanada: 342 citing papers, 3.5% of this breakdownFrance: 325 citing papers, 3.3% of this breakdownSpain: 262 citing papers, 2.6% of this breakdownAustralia: 244 citing papers, 2.5% of this breakdownSwitzerland: 225 citing papers, 2.3% of this breakdownIndia: 223 citing papers, 2.2% of this breakdown
0%22.6%Other 27%

Fields

  • Medicine36.3%
  • Neuroscience26.1%
  • Biochemistry, Genetics and Molecular Biology22.8%
  • Immunology and Microbiology6.5%
  • Materials Science3.3%
  • Engineering1.8%
  • Other3.2%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms7.7%
  • Barrier Structure and Function Studies4.9%
  • Multiple Sclerosis Research Studies4.1%
  • Alzheimer's disease research and treatments2.9%
  • Neurogenesis and neuroplasticity mechanisms2%
  • Immune cells in cancer1.7%
  • Other76.7%

Coauthors

All papers

Open in search
  1. Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

    Authors: , , , , , - Drug Resistance Updates 2015 cited by 1,028

  2. The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence

    Authors: , , , , , , , , , , , , , - Science 2011 cited by 837

  3. Amyloid Beta Induces Oxidative Stress-Mediated Blood–Brain Barrier Changes in Capillary Amyloid Angiopathy

    Authors: , , , , , - Antioxidants and Redox Signaling 2011 cited by 291

  4. Inflammation of the choroid plexus in progressive multiple sclerosis: accumulation of granulocytes and T cells

    Authors: , , , , , , , , - Acta Neuropathologica Communications 2020 cited by 101

  5. Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)

    Authors: , , , , , , , , , , - PLoS ONE 2014 cited by 284

  6. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention

    Authors: , , , , , , , , , , , - Brain 2018 cited by 222

  7. Succinate Is an Inflammation-Induced Immunoregulatory Metabolite in Macrophages

    Authors: , , , , , , , - Metabolites 2020 cited by 138

  8. The influence of cytokines on the integrity of the blood-brain barrier in vitro

    Authors: , , , , , , - Journal of Neuroimmunology 1996 cited by 667

  9. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke

    Authors: , , , , , , , , - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015 cited by 248

  10. Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 127

  11. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling

    Authors: , , , , , , , , , , , , , - The FASEB Journal 2007 cited by 353

  12. Neuroinflammation and Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy

    Authors: , , , , , - Neurodegenerative Diseases 2012 cited by 185

  13. Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology

    Authors: , , , , , , , , , , , - Cell Death and Disease 2019 cited by 98

  14. Human BBB-on-a-chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions

    Authors: , , , , , , , - Frontiers in Molecular Neuroscience 2023 cited by 75

  15. Vascular Hypothesis of Alzheimer Disease

    Authors: , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2021 cited by 99

  16. Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex

    Authors: , , , , , , , , , , , , , - Nature Neuroscience 2022 cited by 90

  17. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration

    Authors: , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2021 cited by 83

  18. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation

    Authors: , , , , , , , , , , , , , , - Journal of Neuroinflammation 2012 cited by 200

  19. Modeling ischemic stroke in a triculture neurovascular unit on-a-chip

    Authors: , , , , , , , , , , , - Fluids and Barriers of the CNS 2021 cited by 70

  20. Induction of brain‐infiltrating T‐bet–expressing B cells in multiple sclerosis

    Authors: , , , , , , , , , , - Annals of Neurology 2019 cited by 105

  21. Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis

    Authors: , , , , , , , - Journal of Neuroinflammation 2017 cited by 145

  22. Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , - Haematologica 2019 cited by 120

  23. Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis

    Authors: , , , , , , , , , , , , , - Journal of Neuroinflammation 2023 cited by 36

  24. Astrocytic ceramide as possible indicator of neuroinflammation

    Authors: , , , , , - Journal of Neuroinflammation 2019 cited by 101